Valeria Micheli

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

Vittorio Pengo, Gentian Denas, Giacomo Zoppellaro et al. · Blood · 2018 · 798 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study

Vittorio Pengo, Amelia Ruffatti, Cristina Legnani et al. · Blood · 2011 · 459 citations · Full text

Medicine, Hematology, Immunology +15

Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies

Silvia S. Pierangeli, Mariano E. Vega-Ostertag, Elena Raschi et al. · Annals of the Rheumatic Diseases · 2007 · 221 citations · Full text

Life Sciences, Immunology, Pathology +17

Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy

Valentina Morena, Laura Milazzo, Letizia Oreni et al. · European Journal of Internal Medicine · 2020 · 207 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study

Gualtiero Palareti, Benilde Cosmi, Cristina Legnani et al. · Blood · 2014 · 188 citations · Full text

Medicine, Hematology, Internal Medicine +13